News
Despite retraction, study using fraudulent Surgisphere data still cited
This despite a quick and widely publicized retraction of the COVID-19 cardiovascular study and stratospheric fall of the health care analytics...
News
FDA panel balks at TriGuard 3 cerebral embolic device for TAVR
The device offers advantages over the approved Sentinel device but could not tamp down stroke rates, the very complication it was designed to...
News
Dissolving pacemaker impressive in early research
The investigational device has shown its mettle in several preclinical models and trades on the same ‘leave nothing behind’ philosophy that’s...
News
Five risk factors may predict thrombus on LAA occlusion implants
With a new clinical risk score, patients deemed at high risk showed a twofold increased rate of this worrisome complication.
News
Statin safety, low muscle pain risk upheld in ‘reassuring’ study
The potential harms are small and the benefit-to-harm balance generally “favorable” for statin use in primary prevention of cardiovascular disease...
News
FDA okays 1-month dual antiplatelet therapy for Abbott’s Xience stents
The new labeling, similarly granted in Europe for as little as 28 days, gives the Xience stents the shortest DAPT indication in the world, Abbott...
News
Reversal agents curb DOAC-related bleeding but deaths still high
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
News
First risk score to predict bleeding risk after TAVR
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
News
Evidence builds for iPhone 12 interference with cardiac devices
Greater public awareness is needed, as are further studies to confirm the results, including differences in susceptibility among devices, the...
News
Medtronic yanks Heartware VAD, calls for halt to new implants
The decision comes as little surprise for the troubled device, which has been the subject of several Class I recalls and linked to an increased...
News
PASCAL mitral valve repair shines at 2 years in CLASP
Follow-up is still ongoing but existing data show sustained favorable outcomes for the system – already approved in Europe and the subject of an...
News
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase...
News
Full 2-year follow-up vindicates EVOLUT Low-Risk TAVR data
Bayesian estimates reported in 2019 based on 12-month data generated questions and had some crying foul over use of that statistical method.
News
LAAOS III: Surgical LAA closure cuts AFib stroke risk by one-third
The finding ‘opens a new paradigm’ for stroke prevention in atrial fibrillation and should change clinical guidelines, experts say.
